Concepedia

Hongfei Hu

HH

Statistics

Publications

3

Citations

75

H-Index

3

Active since

2022

Affiliations

China Pharmaceutical University(Current)

Hongfei Hu is an author at China Pharmaceutical University specializing in oncology, cost-effectiveness analysis, and cancer cost burden.

Publications per year

2022–2024

3

Publications

3

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis

Mingye Zhao, Xingming Pan, Yue Yin et al. · Frontiers in Public Health · 2022 · 47 citations · Full text

, , +17

The Cost Effectiveness of Donafenib Compared With Sorafenib for the First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma in China

Rui Meng, Yingdan Cao, Ting Zhou et al. · Frontiers in Public Health · 2022 · 18 citations · Full text

, , +17

Economic burden and influence factors among hospitalized children with bronchiolitis or pneumonia: a multiregional study in China

Hongfei Hu, Ting Zhou, Jun-Yang Gao et al. · Frontiers in Public Health · 2024 · 10 citations · Full text

, , +17

1–3 of 3